Pulse
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
NIFTY 5024,980.40+0.35%
SENSEX81,720.10+0.28%
NIFTY SHARIAH 254,850.15+0.42%
GOLD 24K (10g)₹75,420+0.38%
SILVER (1kg)₹88,400-0.12%
ACTIVE IPOS8 Open+38% GMP
TCS₹4,124.50+1.18%
INFY₹1,892.40+1.22%
USD/INR₹83.92-0.04%
Artemis Medicare Services Limited

Artemis Medicare Services Limited

NSE: ARTEMISMED
Hospital/Nursing ManagementHealth ServicesSMALL CAPMCap ₹5.08k Cr
₹306.35₹3.35 (+1.11%)

Market Closed • NSE

Market cap₹5.08k Cr
Enterprise value₹5.03k Cr
P/E TTM133.78
Forward P/E24.81
P/B5.19
EPS TTM₹2.29
Forward EPS₹12.35
ROCE14.60%
D/E0.28
Face value₹1.00
52W high₹378.80
52W low₹203.35
Price chart(1Y)
1Y Return:+18.63% (+₹48.10)
H: ₹378.8L: ₹253.2
1W-1.64%
1M-7.41%
3M+13.15%
6M+30.71%
1Y+27.77%
Today at a glance

Day range

₹300.00₹310.00

52 week range

₹203.35₹378.80
Volume143.9K0.11x 20D avg
Free float50.00%-89.40% volume

Artemis Medicare Services Limited closed at INR306.35 (+1.11%) on volume 0.11x its 20-day average, trading 19.13% below its 52-week high.

Technical analysis
RSI (14)39.4Neutral (30–70)
MACDBEARISHBearish (Below signal)
ATR (14)₹12.85High
SMA 20₹329.07BEARISH
SMA 50₹326.53BEARISH
SMA 100₹299.53BULLISH
SMA 200₹271.55BULLISH
CPR bottom₹303.23
Pivot₹303.15
CPR top₹303.08
What changed recently?

2026-Q2

Q2 FY2026 Financial Results

PAT moved +4.4% QoQ

2026-07-10

DIVIDEND Announced

Dividend - Re 0.45 Per Share

2025-07-11

DIVIDEND Announced

Dividend - Re 0.45 Per Share

Shariah audit
Methodology: AAOIFI Shariah Standard No. 21
PASS4/4 criteria
Shariah Compliant
CriteriaNumeratorDenominatorValueThresholdStatus
Interest-bearing debt ratio₹1.41k Cr₹5.08k Cr27.81%≤ 33%PASS
Non-halal income ratio–₹1.08k Cr0.00%≤ 5%PASS
Illiquid assets ratio–₹5.08k Cr—≥ 20%PASS
Receivables ratio–₹5.08k Cr—≤ 49%PASS
Valuation & sector context
MetricCompanySector
P/E133.7882.90
Forward P/E24.81—
P/B5.196.10
EV/EBITDA—18.00
PEG—1.50
Earnings yield0.701.20
Growth & profitability
RevenuePAT
FY25PAT margin 8.80%
FY26PAT margin 9.60%

Revenue and PAT bars use independent scales to make their year-on-year direction readable.

Revenue CAGR 3Y0.00%
Revenue CAGR 5Y+2.90%
PAT CAGR 3Y0.00%
PAT CAGR 5Y+4.60%
Operating margin15.21%
Net margin10.21%
Financial health & cash flow
Net debt₹1.41k CrModerate
Interest coverage—xEBIT / interest
CFO / PAT1.27x3Y average
Net debt / EBITDA—Leverage
Operating cash flow–
Capital expenditure–
Free cash flow–
Financial statements

Complete reported financial history · Values use the company's reporting currency

Hover over the chart for exact reported values. Percentage lines use the right-hand axis.

Fundamental scorecard
Overall60/100
Valuation35/100
Profitability65/100
Financial health80/100

A 0–100 quantitative summary of reported fundamentals. Use the underlying financials and risks for context; the score is not a buy or sell recommendation.

Strengths, risks & investment thesis

Strengths

Low Debt Profile: Debt-to-Equity is comfortable at 0.28x

High Cash Flow Conversion: CFO/PAT averaged 1.27x over last 3 years

Risks

Stretched Valuation: Trading at a high P/E multiple of 133.8x

Bull case

Market Leadership: Established operational scale in Hospital/Nursing Management.

Bear case

Macro Headwinds: Fluctuations in interest rates and sector-specific policy shifts could compress multiples.

Flip condition

Sustained quarterly EBITDA margin expansion above 20% would trigger an upgrade.

Shareholding pattern
Quarterly ownership historyLatest valid period · June 2025

Ownership distribution

Jun 2025Latest holding

Category trends

Hover over a period for exact holdings

70%47%23%0%Sept 2024Dec 2024Jun 2025
14.68%Institutional holding
20.76%Public holding
3Periods available
0.00%Promoter pledged
36.34KShareholders
Corporate Action

Complete dividend, bonus, split, rights and other action history

Record dateCorporate actionInformationAnnouncement dateEx-date
10 Jul 2026Dividend₹0.45 / share—10 Jul 2026
11 Jul 2025Dividend₹0.45 / share—11 Jul 2025
05 Jul 2024Dividend₹0.45 / share—05 Jul 2024
14 Jul 2023Dividend₹0.45 / share—14 Jul 2023
24 Sept 2021Dividend₹10.00 / share—23 Sept 2021
—Annual General MeetingAnnual General Meeting—12 Jul 2021
—Annual General MeetingAnnual General Meeting—15 Sept 2020
Delivery participation

Traded volume and delivery percentage across the latest 20 sessions

Average delivery (20D)46.28%+6.22% latest vs average
Highest delivery58.14%on 14 Oct
Average volume (20D)1.36MTrading-session average
Conviction trendStrengthening+6.22% latest reading
Traded volumeDelivery %
Peer comparison

Compare valuation, latest quarterly performance and year-on-year growth

2 companies
Company nameMarket cap ₹ CrP/E ratioDividend yield %Quarterly sales ₹ CrProfit after tax ₹ CrSales growth %Profit growth %
Artemis Medicare Services Limited
Artemis Medicare Services LimitedARTEMISMED
Current stock
₹5,083.83133.780.00%₹287.32₹31.31+12.68%+49.10%
Dr. Agarwal's Eye Hospital Limited
Dr. Agarwal's Eye Hospital LimitedDRAGARWQ
Open analysis
₹2,453.6331.980.15%₹41.90———
About Artemis Medicare Services Limited
Artemis Medicare Services Limited

Artemis Medicare Services Ltd (AMSL) was incorporated in 2004, operates a 541-bedded multi-specialty tertiary care hospital in Gurgaon. [1][2]

IndiaHealth Services

Questions investors ask
Is Artemis Medicare Services Limited Shariah compliant?

Artemis Medicare Services Limited is currently screened as Shariah Compliant under AAOIFI Shariah Standard No. 21. Business activities align with Shariah permissible sectors. Debt to Market Cap (27.81%) complies with AAOIFI threshold (≤ 33%).

What is Artemis Medicare Services Limited's current valuation relative to peers?

Artemis Medicare Services Limited trades at a P/E of 133.8x compared to the sector median of 82.9x, and a Price-to-Book of 5.2x.

Is the company financially healthy?

The company has a Debt-to-Equity ratio of 0.28x. Interest coverage is comfortable.

What are the historical revenue and profit growth rates?

Over the past 5 years, revenue compounded at 2.9% while net profit growth averaged 4.6%.

Market data is informational and may be delayed. Shariah screening follows the displayed methodology. This is not investment advice.

Market data may be delayed. Quote date: 2026-10-16. Financial figures relate to their stated reporting periods. This information is for research and is not a recommendation to buy or sell.